Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells

Biology of Blood and Marrow Transplantation

Volumn 7, Issue 5, 2001, Pages 247-256

  Keever Taylor, Carolyn A ^a   Margolis, David ^a   Konings, Steve ^a   Sandford, Gordon R ^a   Nicolette, Charles A ^a   Lawendowski, Carla ^a   Burns, William H ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Allogeneic BMT; Cytolytic T cells; Cytomegalovirus; Dendritic cells

Indexed keywords

AMINO ACID; CD8 ANTIGEN; HLA A ANTIGEN; MATRIX PROTEIN; T LYMPHOCYTE RECEPTOR;

ADENOVIRUS; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; B LYMPHOBLAST; CELL ACTIVITY; CELL CLONE; CELL CULTURE; CELL ISOLATION; CELL KILLING; CELL LINE; CELL MATURATION; CELL STIMULATION; CONTROLLED STUDY; CYTOLYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DONOR; FIBROBLAST; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MONOCYTE; MONONUCLEAR CELL; PASSIVE IMMUNIZATION; SKIN BIOPSY; VIRUS INFECTION;

EID: 0034960792     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2001.v7.pm11400946     Document Type: Article

References (35)

1. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation
2. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants
3. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin
4. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones
5. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
6. Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones
7. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes
8. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis
9. Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65
10. B lymphoblastoid cell lines as efficient APC to elicit CD8+ T cell responses against a cytomegalovirus antigen
11. Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: A tool to study the fine specificity of the antiviral response
12. Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors
13. Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants
14. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood
15. Rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma
16. Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells
17. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: Reevaluation of prevalence of IE1-specific CTLs
18. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector
19. Improved methods for the generation of dendritic cells from non-proliferating progenitors in human blood
20. Principles for adoptive T cell therapy of human viral diseases
21. Analysis of reconstituting T cell receptor repertoires in bone marrow transplant recipients
22. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL
23. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides
24. Origin, maturation and antigen presenting function of dendritic cells
25. +-T-cell response to human cytomegalovirus: The 72-kilodalton major immediate-early protein revisited
26. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus
27. High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections
28. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides
29. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product
30. The immunogenicity of human and murine cytomegaloviruses
31. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides
32. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection
33. High efficiency adenovirus-mediated gene transfer to human dendritic cells
34. Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells
35. The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo